Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02178566 · ClinicalTrials.gov registry record · Phase 2
Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso
A Phase 2 study, sponsored by Inova Health Care Services.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT02178566 is a Phase 2 study that was terminated before completion, run by Inova Health Care Services. The registered enrollment target is 1 participants.
The verdict
NCT02178566, a Phase 2 study, was terminated before completion, sponsored by Inova Health Care Services.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The investigators' hypothesis is that pretreating patients with COPD with inhaled treprostinil prior to pulmonary rehabilitation sessions will result in improved exercise tolerance during sessions. This in turn will lead to an increased response to pulmonary rehabilitation, resulting in improved exercise tolerance and quality of life.
Interventions
- DRUG Inhaled Treprostinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02178566
The ClinicalTrials.gov registry entry for NCT02178566 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Inhaled Treprostinil is the first listed.
NCT02178566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02178566 about?
NCT02178566 is a clinical study titled "Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso". The investigators' hypothesis is that pretreating patients with COPD with inhaled treprostinil prior to pulmonary rehabilitation sessions will result in improved exercise tolerance during sessions. This in turn will lead to an increased response to pulmonary rehabilitation, resulting in improved exe...
What is the current status of trial NCT02178566?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2015-08. Estimated completion is 2019-01.
What interventions are being tested in trial NCT02178566?
The interventions under investigation include: Inhaled Treprostinil (DRUG).
Who is sponsoring clinical trial NCT02178566?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.